Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Diabetes Mellitus, Type 2 × Pioglitazone × Clear all

Phase

Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 3 Insulin Resistance 3 Sleep Apnea, Obstructive 1 Metabolic Syndrome 1 Glucose Intolerance 1 Diabetes Mellitus, Type 2 1 Carotid Intimal Medial Thickness 1 1

Interventions

Sitagliptin Phosphate 1 Pioglitazone 1 Metformin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01223196 2016-01-11

PIO-TACE

The University of Texas Health Science Center at San Antonio

Phase 4 Completed

60 enrolled 8 charts

Diabetes Mellitus, Type 2, Insulin Resistance

Data powered by HemOnc (CC BY 4.0) Colophon ⚡